Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Alaunos Therapeutics, Inc. (TCRT) had Return on Tangible Equity of -28.71% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-1.05M |
|
-- |
|
-- |
|
$1.04M |
|
$-1.04M |
|
$-0.01M |
|
$-1.05M |
|
$-1.05M |
|
$-1.05M |
|
$-1.05M |
|
$-1.05M |
|
$-1.05M |
|
$-1.04M |
|
$-1.04M |
|
1.68M |
|
1.68M |
|
$-0.63 |
|
$-0.63 |
|
| Balance Sheet Financials | |
$3.74M |
|
-- |
|
$1.00M |
|
$4.74M |
|
$1.07M |
|
-- |
|
-- |
|
$1.07M |
|
$3.66M |
|
$3.66M |
|
$3.66M |
|
2.08M |
|
| Cash Flow Statement Financials | |
$-1.47M |
|
$0.00M |
|
$3.26M |
|
$1.09M |
|
$2.88M |
|
$1.79M |
|
$0.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-28.71% |
|
|
Return on Tangible Equity |
-28.71% |
-22.20% |
|
-28.71% |
|
$1.76 |
|
$-0.88 |
|
$-0.88 |
|